271 related articles for article (PubMed ID: 20716764)
1. Arginine usage in mycobacteria-infected macrophages depends on autocrine-paracrine cytokine signaling.
Qualls JE; Neale G; Smith AM; Koo MS; DeFreitas AA; Zhang H; Kaplan G; Watowich SS; Murray PJ
Sci Signal; 2010 Aug; 3(135):ra62. PubMed ID: 20716764
[TBL] [Abstract][Full Text] [Related]
2. Toxoplasma gondii rhoptry kinase ROP16 activates STAT3 and STAT6 resulting in cytokine inhibition and arginase-1-dependent growth control.
Butcher BA; Fox BA; Rommereim LM; Kim SG; Maurer KJ; Yarovinsky F; Herbert DR; Bzik DJ; Denkers EY
PLoS Pathog; 2011 Sep; 7(9):e1002236. PubMed ID: 21931552
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens.
El Kasmi KC; Qualls JE; Pesce JT; Smith AM; Thompson RW; Henao-Tamayo M; Basaraba RJ; König T; Schleicher U; Koo MS; Kaplan G; Fitzgerald KA; Tuomanen EI; Orme IM; Kanneganti TD; Bogdan C; Wynn TA; Murray PJ
Nat Immunol; 2008 Dec; 9(12):1399-406. PubMed ID: 18978793
[TBL] [Abstract][Full Text] [Related]
4. Progressive visceral leishmaniasis is driven by dominant parasite-induced STAT6 activation and STAT6-dependent host arginase 1 expression.
Osorio EY; Zhao W; Espitia C; Saldarriaga O; Hawel L; Byus CV; Travi BL; Melby PC
PLoS Pathog; 2012 Jan; 8(1):e1002417. PubMed ID: 22275864
[TBL] [Abstract][Full Text] [Related]
5. Growth factor and Th2 cytokine signaling pathways converge at STAT6 to promote arginase expression in progressive experimental visceral leishmaniasis.
Osorio EY; Travi BL; da Cruz AM; Saldarriaga OA; Medina AA; Melby PC
PLoS Pathog; 2014 Jun; 10(6):e1004165. PubMed ID: 24967908
[TBL] [Abstract][Full Text] [Related]
6. Vagal-α7nAChR signaling is required for lung anti-inflammatory responses and arginase 1 expression during an influenza infection.
Gao ZW; Li L; Huang YY; Zhao CQ; Xue SJ; Chen J; Yang ZZ; Xu JF; Su X
Acta Pharmacol Sin; 2021 Oct; 42(10):1642-1652. PubMed ID: 33414508
[TBL] [Abstract][Full Text] [Related]
7. Macrophage arginase-1 controls bacterial growth and pathology in hypoxic tuberculosis granulomas.
Duque-Correa MA; Kühl AA; Rodriguez PC; Zedler U; Schommer-Leitner S; Rao M; Weiner J; Hurwitz R; Qualls JE; Kosmiadi GA; Murray PJ; Kaufmann SH; Reece ST
Proc Natl Acad Sci U S A; 2014 Sep; 111(38):E4024-32. PubMed ID: 25201986
[TBL] [Abstract][Full Text] [Related]
8. Cytokine-Mediated Regulation of ARG1 in Macrophages and Its Impact on the Control of
Brigo N; Pfeifhofer-Obermair C; Tymoszuk P; Demetz E; Engl S; Barros-Pinkelnig M; Dichtl S; Fischer C; Valente De Souza L; Petzer V; von Raffay L; Hilbe R; Berger S; Seifert M; Schleicher U; Bogdan C; Weiss G
Cells; 2021 Jul; 10(7):. PubMed ID: 34359992
[TBL] [Abstract][Full Text] [Related]
9. Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis.
Pesce JT; Ramalingam TR; Mentink-Kane MM; Wilson MS; El Kasmi KC; Smith AM; Thompson RW; Cheever AW; Murray PJ; Wynn TA
PLoS Pathog; 2009 Apr; 5(4):e1000371. PubMed ID: 19360123
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism.
Hesse M; Modolell M; La Flamme AC; Schito M; Fuentes JM; Cheever AW; Pearce EJ; Wynn TA
J Immunol; 2001 Dec; 167(11):6533-44. PubMed ID: 11714822
[TBL] [Abstract][Full Text] [Related]
11. Regulation of macrophage arginase expression and tumor growth by the Ron receptor tyrosine kinase.
Sharda DR; Yu S; Ray M; Squadrito ML; De Palma M; Wynn TA; Morris SM; Hankey PA
J Immunol; 2011 Sep; 187(5):2181-92. PubMed ID: 21810604
[TBL] [Abstract][Full Text] [Related]
12. Cross talk between histone deacetylase 4 and STAT6 in the transcriptional regulation of arginase 1 during mouse dendritic cell differentiation.
Yang Q; Wei J; Zhong L; Shi M; Zhou P; Zuo S; Wu K; Zhu M; Huang X; Yu Y; Zhang H; Yin H; Zhou J
Mol Cell Biol; 2015 Jan; 35(1):63-75. PubMed ID: 25332236
[TBL] [Abstract][Full Text] [Related]
13. Arginine: master and commander in innate immune responses.
Morris SM
Sci Signal; 2010 Aug; 3(135):pe27. PubMed ID: 20716762
[TBL] [Abstract][Full Text] [Related]
14. Siglec-F is induced by granulocyte-macrophage colony-stimulating factor and enhances interleukin-4-induced expression of arginase-1 in mouse macrophages.
Tateyama H; Murase Y; Higuchi H; Inasaka Y; Kaneoka H; Iijima S; Nishijima KI
Immunology; 2019 Dec; 158(4):340-352. PubMed ID: 31520477
[TBL] [Abstract][Full Text] [Related]
15. Pyropia yezoensis glycoprotein promotes the M1 to M2 macrophage phenotypic switch via the STAT3 and STAT6 transcription factors.
Choi JW; Kwon MJ; Kim IH; Kim YM; Lee MK; Nam TJ
Int J Mol Med; 2016 Aug; 38(2):666-74. PubMed ID: 27353313
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of cytokine-induced JAK-STAT signalling pathways by an endonuclease inhibitor aurintricarboxylic acid.
Chen CW; Chao Y; Chang YH; Hsu MJ; Lin WW
Br J Pharmacol; 2002 Dec; 137(7):1011-20. PubMed ID: 12429573
[TBL] [Abstract][Full Text] [Related]
17. Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation.
Berlato C; Cassatella MA; Kinjyo I; Gatto L; Yoshimura A; Bazzoni F
J Immunol; 2002 Jun; 168(12):6404-11. PubMed ID: 12055259
[TBL] [Abstract][Full Text] [Related]
18. IL-4Rα-dependent alternative activation of macrophages is not decisive for Mycobacterium tuberculosis pathology and bacterial burden in mice.
Guler R; Parihar SP; Savvi S; Logan E; Schwegmann A; Roy S; Nieuwenhuizen NE; Ozturk M; Schmeier S; Suzuki H; Brombacher F
PLoS One; 2015; 10(3):e0121070. PubMed ID: 25790379
[TBL] [Abstract][Full Text] [Related]
19. Pivotal Advance: Arginase-1-independent polyamine production stimulates the expression of IL-4-induced alternatively activated macrophage markers while inhibiting LPS-induced expression of inflammatory genes.
Van den Bossche J; Lamers WH; Koehler ES; Geuns JM; Alhonen L; Uimari A; Pirnes-Karhu S; Van Overmeire E; Morias Y; Brys L; Vereecke L; De Baetselier P; Van Ginderachter JA
J Leukoc Biol; 2012 May; 91(5):685-99. PubMed ID: 22416259
[TBL] [Abstract][Full Text] [Related]
20. EspR promotes mycobacteria survival in macrophages by inhibiting MyD88 mediated inflammation and apoptosis.
Jin C; Wu X; Dong C; Li F; Fan L; Xiong S; Dong Y
Tuberculosis (Edinb); 2019 May; 116():22-31. PubMed ID: 31153514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
